SCHEMBL29326405

SCHEMBL29326405

O=c1[nH]c2cc(-c3ccsc3-c3ccsc3Cl)ccc2c(=O)n1-c1cccc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
HTT P42858 2/20 0.40
GAA P10253 2/20 0.39
NPEPPS P55786 2/20 0.38
TP53 P04637 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
FEN1 P39748 1/20 0.35
PKM P14618 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ITGA4 P13612 1/20 0.33
ITGB7 P26010 1/20 0.33
PTGES O14684 1/20 0.33
TNKS2 Q9H2K2 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
HSP90AA1 P07900 2/20 0.32
CYP1A1 P04798 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29326400 0.94 KDM4E (0.43) KDM4EHTTGAANPEPPSTP53
SCHEMBL27378360 0.89 KDM4E (0.38) KDM4EHTTGAANPEPPSTP53
SCHEMBL27378175 0.83 KDM4E (0.40) KDM4EHTTGAANPEPPSTP53
SCHEMBL29326363 0.81 TNKS2 (0.50) KDM4EHTTGAANPEPPSTP53
SCHEMBL29326224 0.81 NPEPPS (0.48) KDM4EHTTGAANPEPPSTP53
SCHEMBL29326215 0.80 ERCC5 (0.41) KDM4EHTTGAANPEPPSTP53
SCHEMBL29326311 0.80 KDM4E (0.47) KDM4EHTTGAANPEPPSTP53
SCHEMBL29326366 0.80 KDM4E (0.47) KDM4EHTTGAANPEPPSTP53
SCHEMBL29326292 0.79 NPEPPS (0.42) KDM4EHTTGAANPEPPSTP53
SCHEMBL29326316 0.79 KDM4E (0.55) KDM4EHTTGAANPEPPSTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239807-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239807-A1 SARS-COV2 MAIN PROTEASE INHIBITORS ACE2, TMPRSS2, ACE KDM4E 3744/4885HTT 3577/4885GAA 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.